AnalystsAnupam RamaAnupam Rama's Stock Forecasts
AnalystsAnupam Rama
Analyst Ranking
Bottom 2%
#4157 out of 4204 analysts
Average Return
-13.48%
Win Rate
38%35 out of 91
Risk vs Reward
Poor
Good
Anupam Rama's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
G1 Therapeutics IncGTHX | +129.24% | $17.99 | $41.24 | 2017-06-11 - 2018-06-12 | Strong Buy |
Sarepta Therapeutics IncSRPT | +115.98% | $63.22 | $136.54 | 2018-02-21 - 2019-02-21 | Strong Buy |
Mirati Therapeutics IncMRTX | +100.72% | $82.81 | $166.22 | 2020-04-30 - 2021-04-30 | Strong Buy |
Sarepta Therapeutics IncSRPT | +98.76% | $28.16 | $55.97 | 2016-12-22 - 2017-12-22 | Strong Buy |
Kodiak Sciences IncKOD | +78.30% | $76.65 | $136.67 | 2019-12-23 - 2020-11-30 | Strong Buy |
Anupam Rama Analyst Color
Get additional color on Anupam Rama's coverage of popular stocks
Anupam Rama's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zai Lab LtdZLAB | 6 | Strong Buy | $70.00 | +131.71% | Maintains | 6 days ago |
Kiniksa Pharmaceuticals LtdKNSA | 1 | Strong Buy | $20.00 | +79.86% | Maintains | 13 days ago |
Syndax Pharmaceuticals IncSNDX | 2 | Strong Buy | $36.00 | +55.64% | Maintains | 15 days ago |
Springworks Therapeutics IncSWTX | 2 | Strong Buy | $57.00 | +95.34% | Maintains | 15 days ago |
Bridgebio Pharma IncBBIO | 3 | Strong Buy | $23.00 | +64.29% | Maintains | 15 days ago |
Sarepta Therapeutics IncSRPT | 6 | Strong Buy | $206.00 | +56.80% | Maintains | 19 days ago |
G1 Therapeutics IncGTHX | 7 | Hold | $10.00 | +240.14% | Upgrades | 2 months ago |
Rallybio CorpRLYB | 1 | Strong Buy | $21.00 | +361.54% | Initiates Coverage On | 3 months ago |
Sage Therapeutics IncSAGE | 1 | Strong Buy | $60.00 | +36.43% | Maintains | 4 months ago |
Vera Therapeutics IncVERA | 2 | Strong Buy | $38.00 | +408.02% | Maintains | 4 months ago |
Anaptysbio IncANAB | 2 | Strong Sell | $32.00 | +48.01% | Maintains | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 3 | Strong Buy | $79.00 | +25.30% | Maintains | 4 months ago |
Elevation Oncology IncELEV | 2 | Strong Sell | N/A | N/A | Downgrades | 4 months ago |
Cytomx Therapeutics IncCTMX | 2 | Strong Sell | N/A | N/A | Downgrades | 4 months ago |
Neurocrine Biosciences IncNBIX | 8 | Strong Buy | $143.00 | +47.10% | Maintains | 5 months ago |
Solid Biosciences IncSLDB | 2 | Hold | N/A | N/A | Upgrades | 6 months ago |
Mirati Therapeutics IncMRTX | 3 | Strong Buy | $94.00 | +131.93% | Maintains | 6 months ago |
Atara Biotherapeutics IncATRA | 5 | Hold | $10.00 | +235.57% | Downgrades | 8 months ago |
Replimune Group IncREPL | 1 | Strong Buy | $39.00 | +91.08% | Maintains | a year ago |
Passage Bio IncPASG | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Kodiak Sciences IncKOD | 4 | Hold | $21.00 | N/A | Downgrades | a year ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $58.00 | N/A | Initiates Coverage On | a year ago |
Rapt Therapeutics IncRAPT | 1 | Strong Buy | $61.00 | N/A | Initiates Coverage On | a year ago |
Orchard Therapeutics PLCORTX | 2 | Strong Sell | N/A | N/A | Downgrades | a year ago |
Oyster Point Pharma IncOYST | 1 | Hold | $23.00 | N/A | Downgrades | a year ago |
Theravance Biopharma IncTBPH | 1 | Hold | $12.00 | N/A | Upgrades | a year ago |
Vir Biotechnology IncVIR | 5 | Hold | $37.00 | N/A | Upgrades | a year ago |
Protagonist Therapeutics IncPTGX | 2 | Strong Buy | $55.00 | N/A | Upgrades | a year ago |
Chemocentryx IncCCXI | 3 | Hold | $38.00 | N/A | Upgrades | a year ago |
Amicus Therapeutics IncFOLD | 2 | Strong Buy | $16.00 | N/A | Upgrades | a year ago |
Nuvalent IncNUVL | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 2 years ago |
Erasca IncERAS | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 2 years ago |
Infinity Pharmaceuticals IncINFI | 2 | Strong Buy | $6.00 | N/A | Upgrades | 2 years ago |
Cyteir Therapeutics IncCYT | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Day One Biopharmaceuticals IncDAWN | 1 | Strong Buy | $38.00 | N/A | Initiates Coverage On | 2 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | $54.00 | N/A | Downgrades | 2 years ago |
Frequency Therapeutics IncFREQ | 3 | Strong Buy | $56.00 | N/A | Upgrades | 2 years ago |
Bioatla IncBCAB | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 2 years ago |
Allovir IncALVR | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Iteos Therapeutics IncITOS | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 3 years ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $28.00 | N/A | Upgrades | 3 years ago |
Generation Bio CoGBIO | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 3 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | $50.00 | N/A | Downgrades | 3 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Hold | $137.00 | N/A | Downgrades | 3 years ago |
Y Mabs Therapeutics IncYMAB | 1 | Strong Buy | $39.00 | N/A | Initiates Coverage On | 3 years ago |
Dova Pharmaceuticals IncDOVA | 2 | Strong Sell | $20.00 | N/A | Downgrades | 4 years ago |
La Jolla Pharmaceutical CoLJPC | 4 | Hold | $9.00 | N/A | Upgrades | 4 years ago |
Myokardia IncMYOK | 2 | Strong Buy | $81.00 | N/A | Maintains | 5 years ago |
Alexion Pharmaceuticals IncALXN | 2 | Strong Buy | $188.00 | N/A | Maintains | 5 years ago |
Dynavax Technologies CorpDVAX | 2 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Otonomy IncOTIC | 3 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Clearside Biomedical IncCLSD | 2 | Strong Buy | $18.00 | N/A | Maintains | 5 years ago |
Inflarx NvIFRX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Ptc Therapeutics IncPTCT | 2 | Hold | N/A | N/A | Upgrades | 5 years ago |
Prometheus Biosciences IncRXDX | 1 | Strong Buy | $20.00 | N/A | Maintains | 5 years ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Array Technologies IncARRY | 1 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.